S23417 |
KCC-07 |
源葉(MedMol) | ≥98%(HPLC) |
- 產(chǎn)品描述:
KCC-07 is a potent, selective and brain-penetrant MBD2 (methyl-CpG-binding domain protein 2) inhibitor. KCC-07 prevents binding of MBD2 to methylated DNA and activates brain specific angiogenesis inhibitor 1 (BAI1) inducing anti-proliferative BAI1/p53/p21 signaling. Anticancer activity
- 靶點: MBD2 (methyl-CpG-binding domain protein 2);DNAAlkylator/Crosslinker
- 體外研究:
KCC-07 (10 μM; 72 hours; MB cells) treatment clearly inhibited MB cell growth in vitro, consistent with induction of anti-proliferative BAI1/p53/p21 signaling.
KCC-07 (10 μM; 48 hours; MB cells) treatment largely abrogates MBD2 binding to the ADGRB1 promoter and restores BAI1 mRNA and protein expression in BAI1-silent MB cells.
- 體內(nèi)研究:
KCC-07 (100 mg/kg; intraperitoneal injection; 5 days/week; athymic nude mice) treatment inhibits tumor growth and significantly extends the survival of MB xenografts in vivo. Animal Model: Outbred athymic nude mice (females; 8-10 weeks old) injected with MB cells Dosage: 100 mg/kg Administration: Intraperitoneal injection; 5 days/weekResult: Significantly extended the survival of MB xenografts in vivo.
- 參考文獻:
1. Dan Zhu, et al. BAI1 Suppresses Medulloblastoma Formation by Protecting p53 From Mdm2-Mediated Degradation. Cancer Cell. 2018 Jun 11;33(6):1004-1016.e5.
- 溶解性: Soluble in DMSO
- 保存條件: -20℃
- 配置溶液濃度參考:
1mg 5mg 10mg 1 mM 3.713 ml 18.565 ml 37.131 ml 5 mM 0.743 ml 3.713 ml 7.426 ml 10 mM 0.371 ml 1.857 ml 3.713 ml 50 mM 0.074 ml 0.371 ml 0.743 ml
- 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:
本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:
質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)